The latest news about the CMCiB. For more news of research at the IGTP, please see our main website.
News
Boehringer Ingelheim and the Germans Trias i Pujol Research Institute strengthen their collaboration in preclinical research
The agreement between Boehringer Ingelheim and IGTP builds on a collaboration that began in 2020 to improve understanding of cardio-renal-metabolic diseases and their interconnection, and now includes the development of a new line of research to assess the potential of novel molecules in this field.
The Innomed Awards highlight fifteen innovative biomedical projects in their second edition
The Innomed program, an initiative led and coordinated by the IGTP, has concluded the second edition of its GrowInn project incubator with the celebration of the Innomed Awards, which have gathered over 150 people and recognised five projects for their talent and determination.
Study led by IGTP reveals correlation between tuberculosis lesion transcriptomics and patients’ clinical parameters
Researchers from the Experimental Tuberculosis Unit (UTE) at the IGTP and the Germans Trias i Pujol University Hospital have published a study in Nature Communications in which, for the first time, the transcriptomic profile of human tuberculosis lung lesions is correlated with clinical data from the same patients.
Students from Sadako School and UAB Biomedicine visit the IGTP
On May, students from Sadako School and the Autonomous University of Barcelona (UAB) visited the IGTP as part of its educational outreach to promote science among young people.
CMCiB hosts the 4th ISMISS/MIS & Endoscopic Spine Forum
The CMCiB facilities have been chosen to host a hands-on cadaver surgery workshop as part of the 4th ISMISS/MIS & Endoscopic Spine Forum.
The European project SMA-TB concludes with significant advances in tuberculosis treatment
The SMA-TB project, an initiative coordinated by the Experimental Tuberculosis Unit (UTE) at IGTP and funded by the European Commission's H2020 programme, has reached its conclusion after five years of research aimed at improving tuberculosis treatments.